SCHEMBL21364711

SCHEMBL21364711

CC(C)Oc1cccc(-c2n[nH]c3ncnc(N)c23)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 2/20 0.52
▸ PIK3CD O00329 8/20 0.47
▸ PIK3CA P42336 8/20 0.47
▸ PIK3CB P42338 8/20 0.47
▸ PIK3CG P48736 8/20 0.47
▸ PRKDC P78527 8/20 0.47
▸ SRC P12931 7/20 0.47
▸ ABL1 P00519 5/20 0.47
▸ HCK P08631 4/20 0.47
▸ EGFR P00533 3/20 0.47
▸ KDR P35968 3/20 0.47
▸ MTOR P42345 3/20 0.47
▸ EPHB4 P54760 3/20 0.47
▸ PI4KB Q9UBF8 3/20 0.47
▸ BTK Q06187 3/20 0.46
▸ TGFBR1 P36897 1/20 0.40
▸ ACVR1 Q04771 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ RXRA P19793 1/20 0.39
▸ RXRB P28702 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL145785 0.86 SRC (0.56) MAP4K4PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20093561 0.85 BTK (0.47) MAP4K4PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL19414398 0.84 MAP4K4 (0.54) MAP4K4PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL15276905 0.83 PIK3CD (0.45) MAP4K4PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL30387716 0.82 PIK3CD (0.65) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL20793606 0.82 KDM4E (0.47) MAP4K4PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL11149 0.81 BTK (0.51) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL5067148 0.80 PIK3CD (0.44) MAP4K4PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL11909455 0.80 PIK3CD (0.42) MAP4K4PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL13717931 0.80 SRC (0.48) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210401840-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS AG (CH) 2021-12-30 — — US disclosed
US-11020399-B2 Intermediates useful in the synthesis of compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2021-06-01 — — US disclosed
US-10442783-B2 2,3-disubstituted chromen-4-one compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-10-15 — — US disclosed
US-20190282581-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS AG (CH) 2019-09-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10442783-B2 2,3-disubstituted chromen-4-one compounds as modulators of protein kinases PIK3CB, PIK3CD, PDPK1 MAP4K4 117/4885PIK3CD 2/4885PIK3CA 4/4885
US-20210401840-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKCB MAP4K4 129/4885PIK3CD 47/4885PIK3CA 88/4885
US-11020399-B2 Intermediates useful in the synthesis of compounds as modulators of protein kinases MAP4K2, MAP3K20, MAP3K1 MAP4K4 25/4885PIK3CD 288/4885PIK3CA 221/4885
US-20190282581-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKCB MAP4K4 129/4885PIK3CD 47/4885PIK3CA 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback